Literature DB >> 33223008

"Non-criteria" antiphospholipid syndrome: A nomenclature proposal.

Gilberto Pires da Rosa1, Paulo Bettencourt2, Ignasi Rodríguez-Pintó3, Ricard Cervera4, Gerard Espinosa5.   

Abstract

The classification criteria for antiphospholipid syndrome (APS) generate discussion, with a growing impression that certain patients not fulfilling these criteria might be inadequately excluded from the classification. Nonetheless, these "non-criteria" patients are heterogeneously defined across different publications. We reviewed the "non-criteria" APS subgroups depicted in the literature and attempted to organize these subsets in a nomenclature proposal that could be used for research purposes. We established four potential patient profiles, grouped under the broad term "non-criteria APS": (A) "Seronegative APS": patients fulfilling clinical criteria, plus "non-criteria" manifestations, with persistently negative antiphospholipid antibodies (aPL); (B) "Clinical non-criteria APS": patients with "non-criteria" manifestations, plus aPL positivity fulfilling the classification criteria; (C) "Incomplete laboratory APS": patients fulfilling clinical criteria, plus positive aPL, but not fulfilling the classification criteria (low titer aPL); and (D) "Laboratory non-criteria APS": patients fulfilling clinical criteria, with negative or low titer criteria aPL, plus positive "non-criteria" aPL. This categorization could allow for a more homogeneous research approach to APS, enabling more sustained and universal conclusions.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiphospholipid syndrome; Diagnosis; Low titer; Non-criteria; Probable; Seronegative

Mesh:

Substances:

Year:  2020        PMID: 33223008     DOI: 10.1016/j.autrev.2020.102689

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

1.  Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature.

Authors:  Jia-Lei Chen; Xi Yu; Rong Luo; Ming Liu
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

2.  Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study.

Authors:  Alexis F Guédon; Jennifer Catano; Laure Ricard; Charlotte Laurent; Claire de Moreuil; Geoffrey Urbanski; Sophie Deriaz; Grigorios Gerotziafas; Ismail Elalamy; Alexandra Audemard; Francois Chasset; Sonia Alamowitch; Jérémie Sellam; François Maillot; Jean Jacques Boffa; Ariel Cohen; Noémie Abisror; Olivier Fain; Arsène Mekinian
Journal:  Arthritis Res Ther       Date:  2022-01-25       Impact factor: 5.156

3.  A catastrophic seronegative anti-phospholipid syndrome: case and literature review.

Authors:  Vanda Pinto; Augusto Ministro; Nuno Reis Carreira; Ana Cardoso; Catarina Sousa Gonçalves; Mickael Henriques; João Rato; Emanuel Silva; Luís Mendes Pedro
Journal:  Thromb J       Date:  2021-12-20

4.  The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.

Authors:  Gilberto Pires da Rosa; Bernardo Sousa-Pinto; Ester Ferreira; Olga Araújo; Giuseppe Barilaro; Paulo Bettencourt; Ricard Cervera; Gerard Espinosa
Journal:  Arthritis Res Ther       Date:  2022-01-03       Impact factor: 5.156

5.  Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome.

Authors:  Katrien M J Devreese; Stéphane Zuily; Pier Luigi Meroni
Journal:  J Transl Autoimmun       Date:  2021-11-06

Review 6.  Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Ariadna Anunciación-Llunell; Joana Marques-Soares; Josep Pardos-Gea; Francesc Miró-Mur
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

7.  Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study.

Authors:  Sara Del Barrio-Longarela; Víctor M Martínez-Taboada; Pedro Blanco-Olavarri; Ana Merino; Leyre Riancho-Zarrabeitia; Alejandra Comins-Boo; Marcos López-Hoyos; José L Hernández
Journal:  Clin Rev Allergy Immunol       Date:  2021-12-15       Impact factor: 10.817

8.  Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review.

Authors:  Gilberto Pires da Rosa; Ester Ferreira; Bernardo Sousa-Pinto; Ignasi Rodríguez-Pintó; Iva Brito; Alberto Mota; Ricard Cervera; Gerard Espinosa
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

9.  IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.

Authors:  Tatiana Reshetnyak; Fariza Cheldieva; Maria Cherkasova; Alexander Lila; Evgeny Nasonov
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.